
China SXT Pharmaceuticals SXTC
$ 2.58
-1.9%
Annual report 2025
added 02-07-2026
China SXT Pharmaceuticals Total Inventories 2011-2026 | SXTC
Annual Total Inventories China SXT Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 828 K | 795 K | 531 K | 1.02 M | 860 K | 893 K | 1.01 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.02 M | 531 K | 847 K |
Quarterly Total Inventories China SXT Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.02 M | - | 837 K | - | 860 K | - | 867 K | - | 893 K | - | 846 K | - | 1.01 M | - | - | - | 1.27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.27 M | 837 K | 949 K |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amarin Corporation plc
AMRN
|
259 M | $ 14.81 | -0.34 % | $ 6.04 B | ||
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.79 | -7.27 % | $ 4.31 M | ||
|
Biogen
BIIB
|
2.17 B | $ 195.63 | 0.06 % | $ 28.7 B | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Bristol-Myers Squibb Company
BMY
|
2.69 B | $ 60.51 | 1.12 % | $ 123 B | ||
|
Arena Pharmaceuticals
ARNA
|
6.71 M | - | -6.81 % | $ 3.04 B | ||
|
BeiGene, Ltd.
BGNE
|
495 M | - | 0.49 % | $ 251 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.14 M | $ 1.41 | 1.81 % | $ 360 M | ||
|
Amneal Pharmaceuticals
AMRX
|
612 M | $ 14.8 | 1.13 % | $ 4.57 B |